MONISTAT 5 Drug Patent Profile
✉ Email this page to a colleague
When do Monistat 5 patents expire, and when can generic versions of Monistat 5 launch?
Monistat 5 is a drug marketed by Personal Prods and is included in one NDA.
The generic ingredient in MONISTAT 5 is miconazole nitrate. There are twenty-eight drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the miconazole nitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Monistat 5
A generic version of MONISTAT 5 was approved as miconazole nitrate by ACTAVIS PHARMA on November 19th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MONISTAT 5?
- What are the global sales for MONISTAT 5?
- What is Average Wholesale Price for MONISTAT 5?
Summary for MONISTAT 5
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 125 |
Clinical Trials: | 1 |
Patent Applications: | 2,906 |
DailyMed Link: | MONISTAT 5 at DailyMed |
Recent Clinical Trials for MONISTAT 5
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Universidad Autonoma de San Luis Potosà | Phase 4 |
Hospital Central "Dr. Ignacio Morones Prieto" | Phase 4 |
US Patents and Regulatory Information for MONISTAT 5
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Personal Prods | MONISTAT 5 | miconazole nitrate | TAMPON;VAGINAL | 018592-001 | Oct 27, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |